SteadiSetâ„¢ Pilot Study (SteP Study)
Not Applicable
Terminated
- Conditions
- Type 1 Diabetes MellitusIDDMDiabetes Mellitus, Insulin-Dependent, 1Diabetes Mellitus, Type IType 1 Diabetes
- Interventions
- Device: Investigative insulin infusion devcieDevice: Control Device insulin infusion devcie
- First Posted Date
- 2020-10-19
- Last Posted Date
- 2022-02-11
- Lead Sponsor
- Capillary Biomedical, Inc.
- Target Recruit Count
- 13
- Registration Number
- NCT04591925
- Locations
- 🇦🇹
Medizinische Universität Graz, Graz, Austria
"FEXIS": (Feasibility of an Extended Wear CSII Set in Participants With T1DM)
Not Applicable
Completed
- Conditions
- Diabetes Mellitus, Type 1Type 1 Diabetes MellitusDiabetes Mellitus, Insulin-Dependent, 1Type 1 Diabetes
- Interventions
- Device: coil-reinforced soft polymer indwelling cannula
- First Posted Date
- 2020-08-07
- Last Posted Date
- 2023-03-07
- Lead Sponsor
- Capillary Biomedical, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT04503564
- Locations
- 🇦🇺
St Vincent's Hospital (Melbourne) Ltd - Fitzroy, Melbourne, Australia
Pharmacokinetics (PK)/ Pharmacodynamics (PD) of an Extended Wear Infusion Set for Continuous Subcutaneous Insulin Infusion (CSII) in Type 1 Diabetes Mellitus (T1DM) Patients ("PEXIS")
Not Applicable
Completed
- Conditions
- Type 1 DiabetesDiabetes Mellitus, Type 1
- Interventions
- Device: coil-reinforced soft polymer indwelling cannulaDevice: soft Teflon indwelling catheter
- First Posted Date
- 2020-05-21
- Last Posted Date
- 2022-08-11
- Lead Sponsor
- Capillary Biomedical, Inc.
- Target Recruit Count
- 7
- Registration Number
- NCT04398030
- Locations
- 🇺🇸
AMCR Institute, Escondido, California, United States
© Copyright 2025. All Rights Reserved by MedPath